Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

17.29
Delayed Data
As of Jul 29
 +1.19 / +7.39%
Today’s Change
9.16
Today|||52-Week Range
17.55
+2.61%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Nektar Therapeutics have a median target of 17.00, with a high estimate of 20.00 and a low estimate of 14.00. The median estimate represents a -1.68% decrease from the last price of 17.29.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Nektar Therapeutics. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.30
Sales
$34.2M
Reporting Date
Aug 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -116.96%
 
 
 
 
 
 
Growthannually -57.85%
 
 
 
 
 
 

Sales

Growthquarterly -41.98%
 
 
 
 
 
 
Growthannually -26.28%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.